SURESCRIPTS for SURESCRIPTS
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 7, 2026 | — | Replaced |
| 2nd Quarter - Termination (this page) | Sep 1, 2026 | — | Replaced |
| 2nd Quarter - Amendment | Sep 1, 2026 | — | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Efforts to advance health data interoperability; ensure technological advances in the pharmacy services sector, including electronic prescribing ofcontrolled substances, real-time pharmacy benefit information to patients and other stakeholders. Efforts to promote community access to pharmacist services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEANNE PRIMOZIC | VP, Policy and Federal Affairs |
Pharmacy PHA
Efforts to advance health data interoperability; ensure technological advances in the pharmacy services sector, including electronic prescribing ofcontrolled substances, real-time pharmacy benefit information to patients and other stakeholders. Efforts to promote equitable community access to pharmacist services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEANNE PRIMOZIC | VP, Policy and Federal Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.